3D7 Stock Overview
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Willow Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.058 |
| 52 Week High | CA$0.095 |
| 52 Week Low | CA$0.04 |
| Beta | 1.07 |
| 1 Month Change | 1.77% |
| 3 Month Change | -12.88% |
| 1 Year Change | -28.57% |
| 3 Year Change | -94.31% |
| 5 Year Change | -95.11% |
| Change since IPO | -95.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3D7 | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 7.5% | -3.1% | 1.8% |
| 1Y | -28.6% | -22.4% | 2.2% |
Return vs Industry: 3D7 underperformed the German Biotechs industry which returned -22.4% over the past year.
Return vs Market: 3D7 underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| 3D7 volatility | |
|---|---|
| 3D7 Average Weekly Movement | 12.6% |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 3D7's share price has been volatile over the past 3 months.
Volatility Over Time: 3D7's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 19 | Chris Savile | www.willowbio.com |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. is headquartered in Calgary, Canada.
Willow Biosciences Inc. Fundamentals Summary
| 3D7 fundamental statistics | |
|---|---|
| Market cap | €7.80m |
| Earnings (TTM) | -€8.89m |
| Revenue (TTM) | €799.31k |
9.8x
P/S Ratio-0.9x
P/E RatioIs 3D7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3D7 income statement (TTM) | |
|---|---|
| Revenue | CA$1.17m |
| Cost of Revenue | CA$6.80m |
| Gross Profit | -CA$5.63m |
| Other Expenses | CA$7.40m |
| Earnings | -CA$13.03m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.10 |
| Gross Margin | -480.20% |
| Net Profit Margin | -1,111.69% |
| Debt/Equity Ratio | 19.7% |
How did 3D7 perform over the long term?
See historical performance and comparison